Insulin Enhances Gene Expression of <i>Midnolin</i>, a Novel Genetic Risk Factor for Parkinson’s Disease, via Extracellular Signal-Regulated Kinase, Phosphoinositide 3-Kinase and Multiple Transcription Factors in SH-SY5Y Cells-Reference-Cited by-同舟云学术

Insulin Enhances Gene Expression of Midnolin, a Novel Genetic Risk Factor for Parkinson’s Disease, via Extracellular Signal-Regulated Kinase, Phosphoinositide 3-Kinase and Multiple Transcription Factors in SH-SY5Y Cells

Published:2022-03-03 Issue:2 Volume:381 Page:68-78
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Sagehashi Naoki,Obara Yutaro,Maruyama Ohki,Nakagawa Tadashi,Hosoi Toru,Ishii Kuniaki

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference46 articles.

1. GDNF, NGF and BDNF as therapeutic options for neurodegeneration

2. Post hoc analysis of the Exenatide-PD trial-Factors that predict response;Athauda;Eur J Neurosci,2019

3. Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

4. MIDN locus structural variants and Parkinson’s Disease risk;Billingsley;Ann Clin Transl Neurol,2020

5. Genetic risk factors in Parkinson’s disease;Billingsley;Cell Tissue Res,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Midnolin, a Genetic Risk Factor for Parkinson’s Disease, Promotes Neurite Outgrowth Accompanied by Early Growth Response 1 Activation in PC12 Cells;Molecular and Cellular Biology;2024-09-12

2. Viable mutations of mouse midnolin suppress B cell malignancies;Journal of Experimental Medicine;2024-04-16

3. The Contribution of Type 2 Diabetes to Parkinson’s Disease Aetiology;International Journal of Molecular Sciences;2024-04-15

4. The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation;Science;2023-08-25

5. Structural Variants of <i>Midnolin</i>, a Genetic Risk Factor for Parkinson’s Disease, in a Yamagata Cohort;Biological and Pharmaceutical Bulletin;2023-03-01